MedPath

It is study on what happens to patients with liver disease who are hospitalized because their condition suddenly worsens.

Not Applicable
Conditions
Health Condition 1: K74- Fibrosis and cirrhosis of liver
Registration Number
CTRI/2024/02/062896
Lead Sponsor
Govind Ballabh Pant Institute of Post Graduate Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosed cases of chronic liver disease presenting with acute Decompensation with or without prior Decompensation

Exclusion Criteria

1. Acquired or inherited immunodeficiency

2. Prior liver transplant

3. On any immunosuppressive therapy

4. Acute on chronic liver failure

5. Confirmed pregnancy

6. Patient with life-threatening chronic condition like uncontrolled diabetes mellitus, acute Decompensated heart failure, end stage renal disease, severe COPD.

7. Diagnosed case of Hepatocellular carcinoma

8. Extra-hepatic malignancy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of Pre-ACLF, UDC (unstable decompensated cirrhotic), SDC (stable decompensated cirrhotic) in cirrhotic patients who are admitted with an episode of Acute decompensation.Timepoint: Patients will be followed at following intervals - At admission, At 2 weeks, At 1 month, At 2nd month, At 3rd month
Secondary Outcome Measures
NameTimeMethod
The clinical & biochemical predictors of mortality & development of ACLF during the follow-up period. <br/ ><br>The clinical & biochemical predictors of development of stable decompensated cirrhotic during the follow-up period.Timepoint: Patients will be followed at following intervals - At admission, At 2 weeks, At 1 month, At 2nd month, At 3rd month
© Copyright 2025. All Rights Reserved by MedPath